AIM: To investigate the expressions of TGF-β and Endoglin/CD105 in esophageal carcinoma from patients in high incidence area in north China. METHODS: The expressions of TGF-β and Endoglin/CD105 mRNA and protein were detected in 30 esophageal carcinoma samples using RNase protection assay and immunohistochemical staining. RESULTS: TGF-β1, TGF-β3 and Endoglin/CD105 mRNA, other than TGF-β2, were significantly increased in esophageal carcinoma than those of adjacent noncancerous tissue(P0.05). There was a significant correlation between TGF-β3 and Endoglin/CD105 at mRNA level. CONCLUSION: The overexpressions of TGF-β1, TGF-β3 and Endoglin/CD105 may be involved in the regulation of angiogenesis in esophageal carcinoma. Endoglin/CD105 is an important angiogenesis marker as well as regulatory component on cell membrane in regulating the biological function of TGF-β. Endoglin/CD105 could be a potential target to anti-angiogenesis therapy.